The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Protocol-specified final analysis of the phase 3 KEYNOTE-048 trial of pembrolizumab (pembro) as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
 
Danny Rischin
Research Funding - Amgen; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Merck; Regeneron
 
Kevin J. Harrington
Honoraria - Amgen; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Pfizer; Replimune
Consulting or Advisory Role - Amgen (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Merck Sharp & Dohme; Pfizer (Inst)
Speakers' Bureau - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Richard Greil
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Gilead Sciences; MSD; Novartis; Roche; Sandoz; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Merck; MSD; Novartis; Roche; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); Sandoz (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Celgene; Gilead Sciences; Janssen; MSD; Novartis; Roche
 
Denis Soulieres
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ipsen; Merck; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - Ipsen; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Makoto Tahara
Honoraria - AstraZeneca; Bristol-Myers Squibb; Eisai; Merck Serono; MSD; Ono Pharmaceutical
Consulting or Advisory Role - Amgen; Aspyrian Therapeutics; Bristol-Myers Squibb; Celgene; MSD; Ono Pharmaceutical; Pfizer
Research Funding - Aspyrian Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Loxo (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst)
 
Gilberto de Castro
Honoraria - Bristol-Myers Squibb; Merck Serono; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; MSD
 
Amanda Psyrri
Honoraria - Bayer; Bristol-Myers Squibb; Genesis Pharmaceuticals; Merck Serono; MSD Oncology; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Pfizer
Research Funding - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Demo Pharmaceutical; Kura Oncology; Pfizer; Pharmathen; Roche
Travel, Accommodations, Expenses - Ipsen; MSD Oncology; Roche
 
Neus Baste
Consulting or Advisory Role - Bristol-Myers Squibb; Nanobiotix
 
Prakash C. Neupane
Consulting or Advisory Role - AstraZeneca; Pfizer/EMD Serono
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme
Research Funding - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Ase Bratland
Honoraria - Bristol-Myers Squibb; Sanofi
Consulting or Advisory Role - Merck Serono; Sanofi
Research Funding - MSD (Inst)
 
Thorsten Fuereder
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck KGaA; MSD; Pfizer; Roche
Consulting or Advisory Role - Merck KGaA; MSD
Research Funding - Merck KGaA (Inst); MSD (Inst)
 
Brett Gordon Maxwell Hughes
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; MSD Oncology; Pfizer; Roche
Research Funding - Amgen (Inst)
 
Ricard Mesia
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck KGaA; MSD; Nanobiotix; Roche
Speakers' Bureau - Bristol-Myers Squibb; Merck KGaA
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck KGaA; Roche
 
Nuttapong Ngamphaiboon
Honoraria - Roche, Astra Zeneca, Eisai, Amgen, MSD, Novartis
Consulting or Advisory Role - Roche, MSD, Amgen, Novartis, Boehringer Ingelheim, Taiho
Speakers' Bureau - Roche, Astra Zeneca, Eisai, Amgen, MSD, Novartis
Research Funding - MSD, Pfizer, Roche, Astra Zeneca (Inst)
Travel, Accommodations, Expenses - Roche, MSD, Amgen, Novartis, Merck, Eisai, Taiho
 
Tamara Rordorf
Honoraria - Amgen; Bristol-Myers Squibb; MSD
 
Wan Zamaniah Wan Ishak
Honoraria - AstraZeneca; Eisai; Lilly; Pfizer
Consulting or Advisory Role - Lilly; MSD; Roche
Speakers' Bureau - Eisai; Lilly; Pfizer; Roche
Research Funding - Amgen; MSD; Roche
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Lilly; MSD; Pfizer
 
Yayan Zhang
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Fan Jin
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck; Merck
 
Burak Gumuscu
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Barbara Burtness
Consulting or Advisory Role - Aduro Biotech; Alligator Bioscience; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; CUE Biopharma; Debiopharm Group; Genentech/Roche; GlaxoSmithKline; MedImmune; Merck; VentiRx
Travel, Accommodations, Expenses - Boehringer Ingelheim; Debiopharm Group; Merck